The latest news in Health Innovation research at UC San Diego. For more information about Health Innovation at UC San Diego, visit the Health Innovation webpage.
Researchers have developed a new therapy that can be injected intravenously right after a heart attack to promote healing and prevent heart failure. The therapy both prompts the immune system to encourage tissue repair and promotes survival of heart muscle cells after a heart attack.
How do we learn new things? Neurobiologists using cutting-edge visualization techniques have revealed how changes across our synapses and neurons unfold. The findings depict how information is processed in our brain’s circuitry, offering insights for neurological disorders and brain-like AI systems.
Researchers have developed a new drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential. The research highlights the new drug’s potential as a safer and more effective treatment option for conditions like schizophrenia.
With no approved therapies for spinal cord injuries, scientists are looking into the body’s healing mechanisms for clues on recovery. Researchers found that a gene named RYK inhibits wound healing, offering hope for new treatments for paralysis after spinal cord injury.
Those who suffer myasthenia gravis experience muscle weakness that can affect the muscles we use to blink, smile and move our bodies. Researchers at UC San Diego’s School of Biological Sciences used a cutting-edge imaging technique to uncover new details about the mechanisms underlying the disease.
Viruses known as “jumbo phage” are a new hope against the rising antibacterial infection crisis. Researchers have discovered how jumbo phage are able to infect bacteria so efficiently. They found a compartment that protects and hides valuable DNA material from the bacteria’s immune defense system.
New York Times, April 7
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
